Elevation Point Wealth Partners LLC Invests $889,000 in Corteva, Inc. $CTVA

Elevation Point Wealth Partners LLC bought a new position in Corteva, Inc. (NYSE:CTVA) during the first quarter, Holdings Channel reports. The firm bought 10,620 shares of the company’s stock, valued at approximately $889,000.

A number of other large investors have also added to or reduced their stakes in CTVA. JPL Wealth Management LLC bought a new position in shares of Corteva during the 3rd quarter valued at approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new stake in Corteva during the fourth quarter valued at $27,000. Bank of Jackson Hole Trust bought a new position in Corteva during the fourth quarter valued at $28,000. Cornerstone Financial Management LLC bought a new position in Corteva during the fourth quarter valued at $29,000. Finally, Basepoint Wealth LLC purchased a new position in shares of Corteva in the 4th quarter worth $30,000. Institutional investors own 81.54% of the company’s stock.

Analysts Set New Price Targets

Several analysts have recently issued reports on CTVA shares. Royal Bank Of Canada upped their target price on shares of Corteva from $95.00 to $97.00 and gave the company an “outperform” rating in a research report on Thursday, May 7th. Wells Fargo & Company raised their price objective on Corteva from $85.00 to $90.00 and gave the company an “overweight” rating in a research note on Tuesday, April 21st. Berenberg Bank lifted their target price on Corteva from $68.00 to $78.00 and gave the stock a “hold” rating in a report on Thursday, March 26th. Argus boosted their target price on Corteva from $80.00 to $91.00 and gave the company a “buy” rating in a research report on Tuesday, March 31st. Finally, Citigroup raised their price target on Corteva from $83.00 to $85.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Fourteen investment analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $88.90.

Corteva Trading Up 0.6%

Shares of CTVA opened at $86.34 on Tuesday. The firm has a market capitalization of $57.74 billion, a price-to-earnings ratio of 50.79, a PEG ratio of 2.62 and a beta of 0.56. The company has a debt-to-equity ratio of 0.07, a current ratio of 1.47 and a quick ratio of 1.03. Corteva, Inc. has a 1-year low of $60.53 and a 1-year high of $86.51. The company has a 50-day moving average of $79.80 and a 200 day moving average of $76.94.

Corteva (NYSE:CTVA) last issued its earnings results on Tuesday, May 5th. The company reported $1.50 EPS for the quarter, topping analysts’ consensus estimates of $1.18 by $0.32. Corteva had a net margin of 6.50% and a return on equity of 9.95%. The business had revenue of $4.91 billion for the quarter, compared to analyst estimates of $4.64 billion. During the same period last year, the company posted $1.13 earnings per share. The company’s quarterly revenue was up 11.0% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.450-3.700 EPS. On average, research analysts expect that Corteva, Inc. will post 3.72 EPS for the current year.

Corteva Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, June 15th. Shareholders of record on Monday, June 1st were given a dividend of $0.18 per share. The ex-dividend date of this dividend was Monday, June 1st. This represents a $0.72 dividend on an annualized basis and a yield of 0.8%. Corteva’s payout ratio is 42.35%.

About Corteva

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid‑2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.